scholarly journals S1509 A Case of Metastatic Bladder Cancer to the Pancreas Causing Gastric Outlet Obstruction

2021 ◽  
Vol 116 (1) ◽  
pp. S688-S688
Author(s):  
Matthew Tjahja ◽  
Jonathan C. Ramirez ◽  
Steven Smith ◽  
Namisha Thapa ◽  
Nikhil Seth
Keyword(s):  
Bladder Cancer ◽  
Gastric Outlet Obstruction ◽  
Outlet Obstruction ◽  
Metastatic Bladder Cancer

Temporal Trends of Peptic Ulcer Disease in Kashmir, India

JMS SKIMS ◽  
2012 ◽  
Vol 15 (2) ◽  
pp. 136-140
Author(s):  
G M Gulzar ◽  
Showkat A Zargar ◽  
Muzaffar Nazir ◽  
Gul Javid ◽  
Bashir A Khan ◽  
...  
Keyword(s):  
Peptic Ulcer ◽  
Peptic Ulcer Disease ◽  
Gastric Outlet Obstruction ◽  
Temporal Trends ◽  
Outlet Obstruction ◽  
Life Time ◽  
Point Prevalence ◽  
Asymptomatic Group ◽  
Ulcer Disease ◽  
Ulcer Perforation

BACKGROUND: Since late 1960s, the prevalence of peptic ulcer disease and its complications has been steadily decreasing. OBJECTIVE: To ascertain the changing trends in the prevalence and complications of peptic ulcer in Kashmir. METHODS: A cohort of 10474 people aged 15-60 years in district Baramulla of Kashmir was interviewed about symptoms, complications, and surgery related to peptic ulcer. People were enquired about smoking, use of NSAIDs, H2 Receptor antagonists, proton pump inhibitors and endoscopies. All symptomatic and randomly selected group of asymptomatic people underwent esophago-gastro-cluodenoscopy. RESULTS: In symptomatic group, 286 (41.45%) people hod peptic ulcer and in asymptomatic group 24 (5.35%) had peptic ulcer. There were 71 already diagnosed cases of peptic ulcer; totaling 381. Thirty three people had surgery for peptic ulcer. The point prevalence of peptic ulcer was 3.54% and lifetime prevalence 8.96%. The highest prevalence was in 4th decade. Bleeding was seen in 23.63%, gastric outlet obstruction 4.20%, ulcer perforation 0.52%. 9.39% of peptic ulcer patients had undergone surgery. When compared to previous study in 1985 in Kashmir, there was decrease in point prevalence of 25%, in life-time prevalence of 20.14%, Gastric outlet obstruction by 51.7%, ulcer perforation by 87%, surgery rate by 60% and bleeding by a marginal 2%. CONCLUSION: Prevalence of peptic ulcerand its complications (except bleeding) are showing downward trend in Kashmir over the last 20 years. JMS 2012;15(2):136-40

Chemotherapy for metastatic bladder cancer

2015 ◽  
pp. 206-220
Author(s):  
David D Chism ◽  
Andrea B Apolo ◽  
Matthew I Milowsky
Keyword(s):  
Bladder Cancer ◽  
Metastatic Bladder Cancer

Gastrojejunostomy Versus Duodenal Stent Placement for the Palliation of Malignant Gastric Outlet Obstruction: Multicenter Randomized Trial

2009 ◽  
Vol 69 (5) ◽  
pp. AB187 ◽  
Author(s):  
Suzanne Jeurnink ◽  
Ewout W. Steyerberg ◽  
Jeanin E. Van Hooft ◽  
Casper H. Van Eijck ◽  
Matthijs P. Schwartz ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Gastric Outlet Obstruction ◽  
Stent Placement ◽  
Outlet Obstruction ◽  
Malignant Gastric Outlet Obstruction ◽  
Multicenter Randomized Trial ◽  
Duodenal Stent

scholarly journals Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer

2021 ◽  
Vol 9 ◽  
pp. 232470962110356
Author(s):  
Balraj Singh ◽  
Parminder Kaur ◽  
Sachin Gupta ◽  
Nirmal Guragai ◽  
Michael Maroules
Keyword(s):  
Bladder Cancer ◽  
Cancer Immunotherapy ◽  
Locally Advanced ◽  
Complete Response ◽  
First Line ◽  
Novel Therapy ◽  
Metastatic Bladder Cancer ◽  
Metastatic Urothelial Cancer ◽  
Platinum Based Chemotherapy ◽  
Broad Variety

Bladder cancer is the most common urinary tract malignancy. Platinum-based chemotherapy is the first line of treatment in locally advanced or metastatic bladder cancer. Immunotherapy has become a novel therapy option in a broad variety of malignancies including bladder cancer. Immunotherapy is approved as first line of treatment in patients who are ineligible for platinum-based chemotherapy and second-line treatment for metastatic urothelial cancer who progressed after platinum-based treatments. We present the case of an 83-year-old female with metastatic bladder cancer who was chemotherapy ineligible and had complete response with immune checkpoint inhibitor pembrolizumab.

scholarly journals Unusual Tissue – Unusual Issue: Pancreatic Heterotopia Presenting as Gastric Outlet Obstruction

2021 ◽  
pp. 338-343
Author(s):  
Thu L. Nguyen ◽  
Shivani Kapur ◽  
Stephen C. Schlack-Haerer ◽  
Grzegorz T. Gurda ◽  
Milan E. Folkers
Keyword(s):  
Gastric Outlet Obstruction ◽  
Epigastric Pain ◽  
Outlet Obstruction ◽  
Needle Aspiration ◽  
Pancreatic Tissue ◽  
Cystic Mass ◽  
Pancreatic Heterotopia ◽  
History Of

Pancreatic heterotopia (PH) is a common, but typically small (<1 cm), incidental and asymptomatic finding; however, PH should be considered even for large and symptomatic upper gastrointestinal masses. A 27-year-old white woman presented with a 3-week history of burning epigastric pain, nausea, early satiety, and constipation. Physical examination revealed epigastric and right upper quadrant tenderness with normal laboratory workup, but imaging revealed a 5-cm, partly cystic mass arising from the gastric antrum with resulting pyloric stenosis and partial gastric outlet obstruction. Endoscopic ultrasound-guided fine needle aspiration revealed PH – an anomalous pancreatic tissue lying in a nonphysiological site. The patient ultimately underwent a resection and recovered uneventfully, with a complete pathologic examination revealing normal exocrine pancreatic tissue (PH type 2) without malignant transformation. We report a case of heterotopic pancreas manifesting as severe gastric outlet obstruction, in addition to a thorough diagnostic workup and surgical follow-up, in a young adult. Differential diagnoses and features that speak to benignity of a large, symptomatic mass lesion (PH in particular) are discussed.

Sign in / Sign up

Export Citation Format

Share Document